GlassScriptPhysician profile
Elizabeth Chambers
NPI 1659719888
$11,671.57
in general payments reported to CMS, 2019-2025
64 companies · $849 in 2025
The $849 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,128 · 2020: $443 · 2021: $1,607 · 2022: $2,606 · 2023: $2,401 · 2024: $2,637 · 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,776 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,775.69 |
| Education | $111.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,576.35 | 2019-2025 | Ubrelvy, Botox, Duopa |
| Boston Scientific Corporation | $1,386.86 | 2019-2025 | General - Dbs, Vercise, Wavewriter Alpha Prime 16 |
| Teva Pharmaceuticals USA, INC. | $606.47 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Amneal Pharmaceuticals LLC | $582.02 | 2020-2024 | Rytary, Crexont, Ongentys 50mg Capsules 30 |
| Ucb, INC. | $579.09 | 2020-2025 | Briviact, Fintepla, Rystiggo |
| Abbott Laboratories | $413.01 | 2021-2025 | Infinity |
| Merz Pharmaceuticals, LLC | $345.16 | 2022-2025 | Xeomin |
| Medtronic USA, INC. | $323.76 | 2019 | |
| Argenx US, INC. | $290.23 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Eisai INC. | $274.64 | 2020-2025 | |
| Lilly USA, LLC | $274.13 | 2021-2025 | Emgality, Amyvid, Reyvow |
| Novartis Pharmaceuticals Corporation | $269.05 | 2021-2025 | |
| Pfizer INC. | $245.60 | 2019-2025 | |
| Sunovion Pharmaceuticals INC. | $243.93 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $235.96 | 2020-2023 | Nuplazid |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $233.60 | 2019-2025 | Ultomiris, Soliris |
| Biogen, INC. | $224.19 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Neurocrine Biosciences, INC. | $216.07 | 2021-2024 | Ingrezza, Ongentys |
| Ipsen Biopharmaceuticals, INC | $213.16 | 2020-2024 | Dysport |
| Acorda Therapeutics, INC | $177.26 | 2019-2024 | Inbrija |
| Biohaven Pharmaceutical Holding Company LTD. | $169.78 | 2022 | |
| Ge Healthcare | $159.75 | 2021-2024 | |
| Genentech USA, INC. | $150.99 | 2019-2023 | Enspryng, Ocrevus |
| Avion Pharmaceuticals | $142.69 | 2022-2023 | Dhivy |
| Amgen INC. | $136.28 | 2019-2022 | |
| Octapharma USA, INC. | $133.74 | 2023-2025 | Panzyga, Octagam Immune Globulin (Human) |
| Grifols USA, LLC | $133.23 | 2019-2025 | Gamunex-C |
| Sk Life Science, INC. | $118.28 | 2022-2023 | |
| Lundbeck LLC | $115.86 | 2020-2025 | Vyepti, Rexulti |
| Immedica Pharma US, INC. | $97.25 | 2024-2025 | Ztalmy |
| Neurelis, INC. | $95.89 | 2022-2024 | Valtoco |
| Vanda Pharmaceuticals INC. | $90.90 | 2025 | Ponvory |
| Sumitomo Pharma America, INC. | $90.21 | 2023 | Aptiom |
| Celgene Corporation | $90.14 | 2022-2024 | Zeposia |
| Scilex Pharmaceuticals INC. | $83.34 | 2024 | |
| Avanir Pharmaceuticals, INC. | $82.70 | 2019-2022 | |
| Kyowa Kirin, INC. | $79.35 | 2020-2021 | |
| Emd Serono, INC. | $74.13 | 2019-2023 | Mavenclad |
| Genzyme Corporation | $71.95 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $71.39 | 2023 | Onpattro |
| Merz North America, INC. | $70.04 | 2019-2020 | |
| Horizon Therapeutics Plc | $61.48 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $57.96 | 2025 | Hyqvia |
| Jazz Pharmaceuticals INC. | $55.10 | 2022-2024 | |
| Adamas Pharmaceuticals, INC. | $54.75 | 2019-2020 | |
| Upsher-Smith Laboratories LLC | $48.92 | 2021-2022 | |
| Livanova USA, INC. | $47.14 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Allergan, INC. | $45.34 | 2020-2022 | |
| Tg Therapeutics, INC. | $39.81 | 2024 | |
| Medtronic, INC. | $33.30 | 2021-2022 | |
| Aquestive Therapeutics, INC. | $30.95 | 2020-2021 | |
| Revance Therapeutics, INC. | $29.58 | 2025 | Daxxify |
| Biohaven Pharmaceuticals, INC. | $26.53 | 2021 | |
| Mdd US Operations, LLC | $25.37 | 2020 | |
| Xeris Pharmaceuticals, INC. | $23.67 | 2021-2022 | |
| Life Molecular Imaging LTD | $20.29 | 2024 | Neuraceq |
| Hospira, INC. | $19.00 | 2025 | |
| Janssen Pharmaceuticals, INC | $15.45 | 2022 | |
| Harmony Biosciences LLC | $15.08 | 2022 | |
| Ani Pharmaceuticals, INC. | $14.83 | 2024 | Purified Cortrophin Gel |
| Impel Pharmaceuticals INC. | $13.31 | 2023 | Trudhesa |
| Ns Pharma, INC. | $13.03 | 2023 | Viltepso |
| Greenwich Biosciences, INC. | $12.25 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Chambers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.